You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Article metrics

Article menu

Download PDFPDF

Research Article
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019330
Jan 2020880
Feb 202014147
Mar 202020203
Apr 202020202
May 202033332
Jun 20202222144
Jul 2020262613
Aug 2020313211
Sep 202035355
Oct 202034345
Nov 202016167
Dec 202022228
Jan 2021212111
Feb 202120206
Mar 202127278
Apr 202124246
May 202121215
Jun 202133336
Jul 202130309
Aug 202119199
Sep 202132322
Oct 202125255
Nov 202128289
Dec 202130307
Jan 202231328
Feb 2022374111
Mar 202245455
Apr 202220214
May 2022778413
Jun 202239392
Jul 202236408
Aug 202249516
Sep 202229336
Oct 202235378
Nov 2022272920
Dec 202221215
Jan 202331329
Feb 202349507
Mar 2023444410
Apr 202320229
May 202313132
Jun 202317175
Jul 2023303110
Aug 202332327
Sep 202320206
Oct 202340408
Nov 202332324
Dec 2023242415
Jan 202416189
Feb 202442428
Mar 202457578
Total15071542503